Two phenols, bakuchiol (1) and 3-hydroxybakuchiol (2), and two isoflavone glycosides, daidzin (3) and genistin (4) were isolated from Otholobium mexicanum J. W. Grimes (Fabaceae). Moreover, the ability of the raw extract and isolated metabolites to inhibit the enzymes -amylase and -glucosidase was evaluated in vitro. In the α-amylase assay, the methanolic extract exhibited a moderate inhibitory activity with an IC 50 of 470 μg/mL, while inhibition percentages of bakuchiol (1), 3-hydroxybakuchiol (2), and daidzin (3) were less than 25% at the maximum dose tested (1 µM). Genistin (4) exhibited a poor activity with an IC 50 of 805 μM. In the α-glucosidase assay, the methanolic extract exhibited a strong inhibitory activity with an IC 50 value of 32 μg/mL, while 3-hydroxybakuchiol (2) exhibited a moderate inhibitory activity with an IC 50 of 345 μM. Daidzin (3) and genistin (4) exhibited lower inhibitory activity with IC 50 values of 564 μM and 913 μM, respectively. Bakuchiol (1) exhibited a poor inhibitory activity with an inhibition percentage less than 10% at the maximum dose tested (1 mM).
According to the World Health Organization (WHO), diabetes affects over 422 million people, in developed as well as in developing countries [1] . Moreover, hyperglycemia and dyslipidemia factors, increased in the diabetes, are involved in cardiovascular failures frequently affecting patients with this complex metabolic disease. In this context, the WHO has recommended that efficiency, potency and security of plants, traditionally used as anti-diabetic remedies, should scientifically be evaluated [2] . In fact, in spite of many documented beneficial properties, some plants may produce toxic effects in long-term treatments, such as those used in diabetes therapies [3] .
Diabetes is responsible for 4% of all deaths in Ecuador, ranking sixth as the most common cause of death, followed by respiratory diseases [4] . Treatments with plants for the primary health care are practiced in Ecuador by nearly 80% of the people [5] . Otholobium mexicanum (L.f.) J.W. Grimes (Fabaceae), locally called culen, is considered as a medicinal plant in Ecuador and is useful for different purposes, including diarrhea, as a contraceptive, against stomach pain, indigestions, and sheep ticks [5] . Moreover, the leaves are used to prepare a refreshing drink, and the stems infusion is considered an antibacterial remedy. Indeed, this plant is not specifically used as antidiabetic; however, the related species O. pubescens [6] and O. glandulosum [7] have well-known antidiabetic properties. In addition, the antiproliferative activity of O. mexicanum, collected in Peru, has previously been investigated [8] .
One therapeutic approach to treat diabetes is based on the inhibition of hydrolytic enzymes, such as -amylase and -glucosidase. -Amylase hydrolyses -bonds of large, -linked polysaccharides, such as starch and glycogen, yielding glucose and maltose. On the other hand, the membrane-bound intestinal -glucosidases degrade complex carbohydrates into glucose and other monosaccharides in the small intestine, facilitating their digestion. Thus, competitor inhibitors of these enzyme systems reduce the rate of digestion of carbohydrates, resulting in less glucose absorption and consequently, in the short-term, in a decreased blood glucose level. Clinically, -amylase and -glucosidase inhibitors are therefore useful to establish greater glycemic control over hyperglycemia.
Therefore, as a part of our research project on Ecuadorian plants potentially active against diabetes mellitus, a methanolic and a hydromethanolic extracts of O. mexicanum leaves were investigated phytochemically. Moreover, the hypoglycemic properties of the crude extracts and the isolated secondary metabolites were evaluated by measuring their in vitro -amylase and -glucosidase enzyme inhibitory effects [9] . Noteworthy, the phytochemistry as well as the potential anti-diabetic properties of O. mexicanum have not yet been investigated. Suárez et al. 13 C) and 2D NMR spectroscopic measurements, which nicely matched with published spectral data.
α-Amylase and α-glucosidase inhibition activity:
The -amylase and -glucosidase inhibitory effects of the methanolic extract and isolated compounds 1-4 were evaluated using α-amylase from porcine pancreas (Type IV-B) and α-glucosidase from Saccharomyces cerevisiae (Type I).
In the α-amylase assay, the methanolic extract exhibited a moderate inhibitory activity with an IC 50 value of 470 μg/mL while bakuchiol (1), 3-hydroxybakuchiol (2) and daidzin (3) showed a weak inhibitory activity with inhibition percentages < 25% at the maximum dose tested (1 µM). Genistin (4) exhibited an IC 50 value of 805 µM. In the α-glucosidase assay, the methanolic extract exhibited a strong inhibitory activity with an IC 50 value of 32 μg/mL, while 3-hydroxybakuchiol (2) exhibited an IC 50 of 345 μM and inhibition percentage of bakuchiol (1) was < 10% at the maximum dose tested (1 mM). On the other hand, IC 50 values of the inhibitory activities of daidzin (3) and genistin (4) were 564 μM and 913 μM, respectively. Therefore, regarding their activity, 3hydroxybakuchiol (2) and daidzin (3) did not differ significantly from the commercially available α-glucosidase inhibitor acarbose, which showed an IC 50 = 377 μM in the same test.
The Peruvian medicinal plant Otholobium pubescens exhibited antidiabetic properties that have been attributed to the phenolic compound bakuchiol (1) [6] . Indeed, bakuchiol was active in the db/db mice model in a dose-dependent manner; however, it displayed no hypoglycemic effect when tested in lean mice at 250 mg/Kg q.d. [6] . Bakuchiol (1) was also isolated from Psoralea corylifolia and exhibited a moderate glycosidase inhibitory activity with an IC 50 value of 115 μM [13] . To our knowledge, no in vitro inhibitory activity was previously reported for 3-hydroxybakuchiol (2) and isoflavonoids 3 and 4. Interestingly, daidzein, which is the aglycone of daidzin (3) inhibited α-glucosidase and α-amylase enzymes with IC 50 values of 48 μM and 301 μM, respectively, thus indicating that daidzein was more effective than acarbose [14] . Similarly, the isoflavone genistein, which is the aglycone of genistin (4),has been reported to reduce the activity of -glucosidase in a dose-responsive manner, showing an IC 50 value of 50 nM [15] . Thus, the remarkable α-glucosidase inhibitory activities of daidzein and genistein were about 20 times higher than those reported here for their glucosides 3 and 4, respectively. These differences may be related to the mode and mechanism of enzyme inhibition and deserve further investigation.
In conclusion, the α-amylase and -glucosidase inhibitory activity of O. mexicanum offers the possibility to develop this plant as a promising anti-diabetic natural remedy. However, these effects can be attributed, only in part, to the isolated compounds 1-4. Thus, the activity might mainly be due to synergistic effects or to the presence of minor constituents with higher bioactivity, still to be isolated. Moreover, the yeast -glucosidase is known to be very different from mammalian digestive enzymes, suggesting that further experiments should be extended to the inhibition of mammalian intestinal -glycosidases.
Experimental

General Experimental Procedures:
Chromatographic and spectrometric instruments and procedures were reported previously [16] . In addition, a Varian Premium Shielded spectrometer, operating at 400 MHz ( 1 H) and 100 MHz ( 13 C) was used. Preparative MPLC separations were performed on a Biotage Isolera One instrument equipped with home-made silica gel and RP-18 filled cartridges and a diode UV detector set at 254-366 nm. α-Amylase and α-glucosidase were isolated from porcine pancreas (Type IV-B, Sigma A3176, Saint Louis,MO, USA) and from Saccharomyces cerevisiae (Type I, Sigma G5003), respectively. Starch and p-nitrophenyl-α-D-glucopyranoside (p-NPG-Sigma, N1377) were used as the substrates for α-amylase and αglucosidase, respectively. A microplate reader (EPOCH 2, Biotek Instruments Inc. Winoosky, VT, USA) was used for both assays. Extraction and Isolation: Two lots, 300 g and 200 g, respectively, of air-dried leaves of O. mexicanum were separately extracted. The first sample was directly macerated in MeOH at rt, three times overnight. After solvent evaporation, the residue (32 g) was successively exposed to n-hexane, CHCl 3 , EtOAc, MeOH, yielding after evaporation in vacuo, residues A (10.3 g), B (5.56 g), C (8.6 g) and D (7.4 g), respectively. A sample (4.0 g) of C was directly chromatographed on a silica gel column, eluted with a solvent gradient from n-hexane-EtOAc (1:2) to EtOAc-MeOH (9:1). Elution with n-hexane-EtOAc (1:9) afforded bakuchiol (1) (342.2 mg), whereas 100% EtOAc gave a fraction which was further purified on a silica gel column. Elution with EtOAc-CHCl 3 (4:1), gave 3-hydroxybakuchiol (2) (43.2 mg). The second leaf lot was extracted successively with EtOAc, MeOH and MeOH-H 2 O (7:3, v/v) at rt, three times for 1 h each, yielding, after solvent evaporation in vacuo, residues A´ (8. 
α-Amylase inhibition assay:
The method reported by Xiao et al. [17] was followed with minor modifications. Acarbose was used as the positive control. A starch solution was prepared by dissolving 1 g in 50 mL of 0.4 M NaOH and heating at 100 °C for 5 min. After cooling in ice-water, the pH was adjusted to 7 with 2 M HCl and then H 2 O was added to a final volume of 100 mL. Tested sample solutions were prepared by dissolving 10 mg in 1 mL of MeOH-H 2 O (1:1); several dilutions with PBS (SIGMA-P4417) were made in case of complete enzyme inhibition. The PBS (35 μL, pH 7.4), the starch (20 μL) and the sample (5μL) solutions were mixed in a 96-microtiter plate, and the mixture was preincubated at 37 °C for 1 min. Then 20 μL of a 50 μg/mL α-amylase solution (SIGMA-A3176) was added to each well. The plate was incubated for 15 min. The reaction was terminated by adding 0.1 M HCl (50 μL); subsequently, 150 μL of a 0.5 mM iodine solution (0.5 mM I 2 and 0.5 mM KI) was added and the absorbance was measured in an EPOCH 2 (BIOTEK ®) microplate reader at 580 nm. Inhibitory activity (%) was calculated according to the formula [18] :
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where AbS1 is the absorbance of the incubated solution containing sample, starch and amylase, AbS2 is the absorbance of incubated solution containing sample and starch, AbS3 is the absorbance of incubated solution containing starch and amylase, and AbS4 is the absorbance of incubated solution containing starch. IC 50 values were calculated by curve fitting of data (GraphPad Prism 5.0).
α-Glucosidase inhibition assay:
The α-glucosidase inhibitory activity was determined using a 96-well microtiter plate with pnitrophenyl-α-D-glucopyranoside (PNPG, SIGMA N1377 ) as the substrate, according to the method described by Tao et al. [19] , with minor modifications. Acarbose was used as the positive control. Tested sample solutions were prepared by dissolving 10 mg in 1 mL of MeOH-H 2 O (1:1); several dilutions with PBS were made in case of complete enzyme inhibition. PBS (75 μL) was mixed with sample solution (5 μL) and 20 μL of the enzyme solution (SIGMA G5003, 0.15U/mL in PBS pH 7.4); subsequently, the mixture was preincubated at 37 °C for 5 min before initiating the reaction by adding the substrate. Then, PNPG (5mM in phosphate buffer, pH 7.4, 20 μL) was added and incubated at 37 °C. The amount of p-NP released was measured in an EPOCH 2 (BIOTEK ®) microplate reader at 405 nm for 60 min, recording the absorbance every 5 min. The results were expressed as inhibition percentage by means of the formula [20] :
where Ao is the absorbance recorded for the enzymatic activity without inhibitor (control), and As is the absorbance recorded for the enzymatic activity in presence of the inhibitor (sample). IC 50 values were calculated by the GraphPad Prism 5.0 software.
